{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T02:56:31Z","timestamp":1768272991130,"version":"3.49.0"},"reference-count":0,"publisher":"Salvia Medical Sciences Ltd","license":[{"start":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T00:00:00Z","timestamp":1732924800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Galen Med J"],"abstract":"<jats:p>Background: Alpha-pinene is an organic compound with anticancer properties. This compound has been used as a\u00a0therapeutic factor in breast cancer (BC). miR-21 causes cancer cell invasion by inhibiting Phosphatase and tensin homolog (PTEN). The present study evaluates the potential effect of Alpha-piene on the expression of PTEN and miR-21 genes in BC cells (MCF-7 cell line). Materials and Methods: In this study, the MCF-7 cell line was used. The cells were treated with Alpha- pinene. The viability of cells with different Alpha-pinene concentrations (i.e., 40, 50, 100, 150, and 200 \u03bcM) was evaluated with MTT assay. The expression of PTEN and miR-21 genes was evaluated using RT-qPCR. Results: The survival rate of cells in all concentrations was higher 24 h after treatment compared to 48 h after the treatment (P&lt;0.0001). The expression of miR-21 in cells treated with 100 and 50 \u03bcM of Alpha- pinene reduced significantly compared to the control cells(P&lt;0.001). PTEN gene expression was exactly the opposite of miR-21. Therefore, its expression increased significantly in cells treated with 100 \u03bcM of Alpha- pinene compared to the control cells (P&lt;0.0001). Conclusion: In general, the use of Alpha- pinene led to decreased and increased expression of miR-21 and PTEN, respectively. These changes lead to the reduction of invasion and proliferation of BC cells. Therefore, the Alpha- pinene combination can be used as a therapeutic strategy to treat patients.<\/jats:p>","DOI":"10.31661\/gmj.v13i.3613","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T16:54:29Z","timestamp":1736182469000},"page":"e3613","source":"Crossref","is-referenced-by-count":3,"title":["Therapeutic Potential of Alpha-pinene in Breast Cancer: Targeting miR-21 and PTEN Gene  Expression"],"prefix":"10.31661","volume":"13","author":[{"given":"Mohammad","family":"Yazdi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahdi","family":"Alaee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shana","family":"Ahadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parisa","family":"Khanicherag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham","family":"Ghayem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghasem","family":"Farhadi Galil Babadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Ghiasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojgan","family":"Azadpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"16705","published-online":{"date-parts":[[2024,11,30]]},"container-title":["Galen Medical Journal"],"original-title":[],"link":[{"URL":"https:\/\/journals.salviapub.com\/index.php\/gmj\/article\/download\/3613\/3003","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.salviapub.com\/index.php\/gmj\/article\/download\/3613\/3004","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.salviapub.com\/index.php\/gmj\/article\/download\/3613\/3003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T16:54:30Z","timestamp":1736182470000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.salviapub.com\/index.php\/gmj\/article\/view\/3613"}},"subtitle":["Alpha-pinene in Breast Cancer: Targeting miR-21 and PTEN"],"short-title":[],"issued":{"date-parts":[[2024,11,30]]},"references-count":0,"URL":"https:\/\/doi.org\/10.31661\/gmj.v13i.3613","relation":{},"ISSN":["2322-2379","2588-2767"],"issn-type":[{"value":"2322-2379","type":"electronic"},{"value":"2588-2767","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,30]]}}}